A detailed history of Nebula Research & Development LLC transactions in Pfizer Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 23,599 shares of PFE stock, worth $635,049. This represents 0.08% of its overall portfolio holdings.

Number of Shares
23,599
Previous 23,210 1.68%
Holding current value
$635,049
Previous $649 Million 5.16%
% of portfolio
0.08%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $10,775 - $12,210
389 Added 1.68%
23,599 $683 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $44,659 - $52,332
-1,768 Reduced 7.08%
23,210 $649 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $180,246 - $206,980
6,962 Added 38.64%
24,978 $693 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $470,758 - $611,463
18,016 New
18,016 $519 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $151B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.